Utilization of cancer immunotherapy in sub-Saharan Africa

Utilization of cancer immunotherapy in sub-Saharan Africa

IntroductionThe Lancet Oncology Commission for sub-Saharan Africa (SSA) predicts that cancer deaths will double from 520,158 per year to more than 1 million per year by the year 2040. These striking figures indicate a need to urgently evaluate cancer treatment infrastructure and resources in the reg...

Full description

Bibliographic Details
Main Authors: Elizabeth Olatunji, Saloni Patel, Katy Graef, Adedayo Joseph, Nwamaka Lasebikan, Abba Mallum, Chinelo Chigbo, Elizabeth Jaffee, Wil Ngwa
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Oncology
Subjects:
immunotherapy
sub-Saharan Africa
global oncology
cancer
immunotherapy training
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1266514/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1266514/full

Similar Items